Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Cerebral Palsy
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-08-20; most recent amendment 2025-04-04.
Trial Details
NCT Number NCT05018819
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Cerebral Palsy
Enrollment 15 participants
Start Date 2022-02-01
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-04-08